Mass Spec
News on mass spectrometry technology and applications in genetics, genomics, and molecular diagnostics.
The IMTAC discovery platform is at the center of BridGene's efforts to identify new drugs and new targets for current drugs.
New Initiative Aims to Drive Development, Use of Capillary Electrophoresis in Top-Down Proteomics
Premium
CE has seen significant uptake within biopharma for characterization of intact proteins and has made inroads into both bottom-up and top-down proteomics.
Scienion, Cellenion Enter Exclusive Licensing Deal, Partnership With Pacific Northwest National Lab
The two companies have exclusively licensed PNNL's microfluidic NanoPOTS platform and entered into a research agreement with EMSL to develop it toward commercial use.
InterVenn Biosciences Using New Funding to Develop Glycoproteomic Immunotherapy Response Assay
Premium
The company is building a blood-based glycoproteomic assay intended to help doctors predict which cancer patients will respond to checkpoint inhibitors.
908 Devices Q2 Revenues Drop 25 Percent but Beat Wall Street Estimate
The mass spec device maker attributed the revenue decline to a one-time shipment made to a single customer in the second quarter last year.